Clinical Trial Update: Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B [Phase 3]

View source ↗

Summary

This Phase 3 trial update compares lamivudine plus adefovir against telbivudine plus adefovir in lamivudine-resistant chronic hepatitis B; the status is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir Dipivoxil (Adefovir dipivoxil)
• Lamivudine (lamivudine)
• Telbivudine (telbivudine)

Snippet

Sponsor: Yonsei University | Conditions: Chronic Hepatitis B | Phase 3 | Status: UNKNOWN